Jill Quigley Email

Chief Operating Officer . Passage Bio

Philadelphia, PA

Location

LinkedIn

Current Roles

Employees:
92
Revenue:
$25.9M
About
Passage Bio was launched with the vision to be a first in class fully-integrated genetic medicines company developing life transforming AAV-delivered in vivo therapeutics for the treatment of rare CNS diseases. In collaboration with the University of Pennsylvania Gene Therapy Program, Philadelphia-based Passage Bio plans to advance a portfolio of 6 rare disease indications in the neuro/CNS genetic space through IND-enabling studies using best-in-class AAV technology and know-how. Subsequently, Passage Bio will be responsible for all clinical development and will collaborate with Penn?s Orphan Disease Center to support these efforts.
Passage Bio Address
2001 Market St
Philadelphia, PA
United States

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.